Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
β Scribed by Keith Wheatley; Cassandra L. Brookes; Andrew J. Howman; Anthony H. Goldstone; Donald W. Milligan; Archibald G. Prentice; Anthony V. Moorman; Alan K. Burnett; on behalf of the United Kingdom National Cancer Research Institute Haematological Oncology Clinical Studies Group; Acute Myeloid Leukaemia Subgroup
- Book ID
- 108676267
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 193 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BACKGROUND. Data relating to the impact of bone marrow transplantation (BMT) on sexual functioning are equivocal; some studies have shown no major impact whereas others demonstrate a significant adverse effect on sexual health in patients treated with BMT. Further clarification is required to facili
## Abstract ## BACKGROUND. Data on the impact of age in acute myeloid leukemia (AML) patients <30 years treated in pediatric and adult trials are scarce. ## METHODS. In all, 891 patients <18 years were treated in the pediatric trials AMLβBFM 93/98 and 290 adolescents and young adults (>16 to <30
## Abstract Rearrangements of chromosome band 3q26.2 lead to overexpression of the __EVI1__ gene and are associated with a poor prognosis in myeloid malignancies. __EVI1__ is also overexpressed in some cases without 3q26 rearrangements. To uncover its prognostic significance in this patient group,